Nuvectra Corporation (NVTR) Provides Update on FDA Review of Virtis PMA, CE Mark Applications
Tweet Send to a Friend
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
